Table 1.
Baseline clinical characteristics and pathological characteristics of the patients in the MMF and control groups.
| Characteristics | Group | P-value | |
|---|---|---|---|
| MMF+GC | GC | ||
| Cases, n | 41 | 20 | |
| Male/female, n | 23/18 | 9/11 | 0.415 |
| Age (year) | 7.61±2.87 | 7.79±2.88 | 0.82 |
| Time from discovery to biopsy (days) | 21.29±7.37 | 17.60±8.29 | 0.083 |
| 24 hr proteinuria (mg/m2) | 96.69±50.12 | 82.15±29.36 | 0.236 |
| Serum albumin (g/L) | 36.45±5.41 | 37.98±4.44 | 0.278 |
| Serum creatinine (μmol/L) | 44.00±10.09 | 45.47±11.37 | 0.610 |
| White blood cell (×109 L−1) | 10.30±3.98 | 8.83±2.16 | 0.126 |
| Hemoglobin (g/L) | 129.05±10.54 | 124.15±12.44 | 0.114 |
| Platelet (×109 L−1) | 345.71±96.35 | 335.70±79.25 | 0.689 |
| eGFR (ml/min/1.73 m2) | 146.87±32.73 | 139.11±47.53 | 0.458 |
| IgA (mg/dl) | 2.03±0.57 | 1.94±0.42 | 0.538 |
| Extra renal manifestations at admission, n (%) | |||
| Palpable purpura | 41/41 | 20/20 | 1 |
| Gastrointestinal involvement | 21/41 (51.2%) | 12/20 (60%) | 0.518 |
| Arthritis | 24/41 (58.5%) | 13/20 (65%) | 0.628 |
| Follow-up time (month), median (range) | 23.29±6.25 | 27.1±10.13 | 0.075 |